![PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/251be2484ab726805c25860ba5917364701380f4/2-Table1-1.png)
PDF] Diagnostic Role of Serum Free-to-Total Prostate Specific Antigen (PSA) Ratio in Prostate Cancer with Serum Total Concentration of PSA below 4 ng/mL. | Semantic Scholar
![Clinical characteristics of patients with PsA without spondylitis and... | Download Scientific Diagram Clinical characteristics of patients with PsA without spondylitis and... | Download Scientific Diagram](https://www.researchgate.net/publication/362577142/figure/tbl2/AS:11431281083549395@1662655700428/Clinical-characteristics-of-patients-with-PsA-without-spondylitis-and-with-psoriatic.png)
Clinical characteristics of patients with PsA without spondylitis and... | Download Scientific Diagram
![SOLVED: Odds Ratio (OR) 95% Cl for OR B SE (B) P-value Lower Upper Constant -0.493 1.137 0.61 0.665 Age PSA -0.006 0.017 0.99 0.961 1.028 0.051 0.009 1.05 <.001 1.033 1.072 VOL -0.016 0.007 0.98 0.016 0.971 0.997 N = 379, Nagelkerke R2 0.183 Hosmer ... SOLVED: Odds Ratio (OR) 95% Cl for OR B SE (B) P-value Lower Upper Constant -0.493 1.137 0.61 0.665 Age PSA -0.006 0.017 0.99 0.961 1.028 0.051 0.009 1.05 <.001 1.033 1.072 VOL -0.016 0.007 0.98 0.016 0.971 0.997 N = 379, Nagelkerke R2 0.183 Hosmer ...](https://cdn.numerade.com/ask_images/a280e117be6c43358e97fdea5d38daa8.jpg)
SOLVED: Odds Ratio (OR) 95% Cl for OR B SE (B) P-value Lower Upper Constant -0.493 1.137 0.61 0.665 Age PSA -0.006 0.017 0.99 0.961 1.028 0.051 0.009 1.05 <.001 1.033 1.072 VOL -0.016 0.007 0.98 0.016 0.971 0.997 N = 379, Nagelkerke R2 0.183 Hosmer ...
![Frontiers | Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients Frontiers | Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients](https://www.frontiersin.org/files/Articles/492017/fonc-09-01286-HTML/image_m/fonc-09-01286-g001.jpg)
Frontiers | Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients
![Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data Cancers | Free Full-Text | Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data](https://www.mdpi.com/cancers/cancers-15-00261/article_deploy/html/images/cancers-15-00261-g001.png)